News & Articles

University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery

TrueBinding signs multi-product commercial-use license to develop stable, antibody-expressing cell lines using Horizon’s gene-edited CHO GS knockout platform

87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus

Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time

New platform provides faster identification of defects that impact device performance

Leading clinical scientists and health professionals have come together to discuss the latest diagnostic and point-of-care solutions at this critical time

The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting

Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe

Find out how LC-MS technology is being used to quantify the experimental drug remdesivir

The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test

The NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered

Thermo Fisher Scientific’s ImmunoCAP Specific IgE alpha-Gal Allergen Component test helps clinicians pinpoint a potentially fatal allergy often resulting from tick bites

This on-demand webinar shows how cutting-edge liquid handling, automation, and detection technologies can increase speed and efficiency in your lab

AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage

Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)

Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus

The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets